Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume 38, Issue 12, Pages 847-855
Publisher
Springer Nature
Online
2015-07-02
DOI
10.1038/hr.2015.69
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the Antialbuminuric Effects of Benidipine and Hydrochlorothiazide in Renin-Angiotensin System (RAS) Inhibitor-Treated Hypertensive Patients with Albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) Study
- (2014) Katsuyuki Ando et al. International Journal of Medical Sciences
- Functional and pharmacological consequences of the distribution of voltage-gated calcium channels inthe renal blood vessels
- (2013) P. B. L. Hansen Acta Physiologica
- Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis
- (2013) P. Susantitaphong et al. AMERICAN JOURNAL OF HYPERTENSION
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial
- (2013) Hiromi Rakugi et al. HYPERTENSION RESEARCH
- Comparison of the Antialbuminuric Effects of L-/N-type and L-type Calcium Channel Blockers in Hypertensive Patients with Diabetes and Microalbuminuria: The Study of Assessment for Kidney Function by Urinary Microalbumin in Randomized (SAKURA) Trial
- (2013) Katsuayuki Ando et al. International Journal of Medical Sciences
- L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
- (2013) Tomohiko Kanaoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a Novel Calcium Channel Blocker on Abnormal Nocturnal Blood Pressure in Hypertensive Patients
- (2013) Kazuomi Kario et al. Journal of Clinical Hypertension
- Switching to an L/N-Type Calcium Channel Blocker Shows Renoprotective Effects in Patients with Chronic Kidney Disease: The Kyoto Cilnidipine Study
- (2013) T Hatta et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: Longitudinal data analysis from Fukushima Research of Hypertension (FRESH)
- (2013) Hirohide Yokokawa et al. Obesity Research & Clinical Practice
- Study of Sustained Blood Pressure-Lowering Effect of Azelnidipine Guided by Self-Measured Morning and Evening Home Blood Pressure: Subgroup Analysis of the At-HOME Study
- (2013) Kazuomi Kario et al. Drugs in research & development
- L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease
- (2012) Masanori Abe et al. HEART AND VESSELS
- Renoprotective and antioxidant effects of cilnidipine in hypertensive patients
- (2012) Takeshi Soeki et al. HYPERTENSION RESEARCH
- Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
- (2012) Shinji Takai et al. HYPERTENSION RESEARCH
- N-type Calcium Channel Inhibition With Cilnidipine Elicits Glomerular Podocyte Protection Independent of Sympathetic Nerve Inhibition
- (2012) Bai Lei et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Stephen S Lim et al. LANCET
- Notice
- (2012) Kidney International Supplements
- Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy
- (2011) Hidehisa Sasaki et al. Journal of Atherosclerosis and Thrombosis
- Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients
- (2011) Hidenori Yoshii et al. Journal of Diabetes Investigation
- Urinary Albumin Excretion During Angiotensin II Receptor Blockade: Comparison of Combination Treatment With a Diuretic or a Calcium-Channel Blocker
- (2010) Yoshio Matsui et al. AMERICAN JOURNAL OF HYPERTENSION
- Introduction
- (2010) AMERICAN JOURNAL OF KIDNEY DISEASES
- Comparative Effects of Benidipine and Amlodipine on Proteinuria, Urinary 8-OHdG, Urinary L-FABP, and Inflammatory and Atherosclerosis Markers in Early-Stage Chronic Kidney Disease
- (2010) Tsukasa Nakamura et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Renoprotective Effect of Calcium Channel Blockers in Combination with an Angiotensin Receptor Blocker in Elderly Patients with Hypertension. A Randomized Crossover Trial Between Benidipine and Amlodipine
- (2010) Koichi Miyagawa et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Antiproteinuric Effect of Cilnidipine in Hypertensive Japanese Treated with Renin-Angiotensin-System Inhibitors - A Multicenter, Open, Randomized Trial Using 24-Hour Urine Collection
- (2010) Yoshikazu Miwa et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria
- (2010) Masanori Abe et al. HYPERTENSION RESEARCH
- Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte
- (2010) Yu-Yan Fan et al. JOURNAL OF HYPERTENSION
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease
- (2009) Masanori Abe et al. HYPERTENSION RESEARCH
- Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
- (2009) Toshihiko Ishimitsu et al. HYPERTENSION RESEARCH
- Add-On Benefits of Amlodipine and Thiazide in Nondiabetic Chronic Kidney Disease Stage 1/2 Patients Treated with Valsartan
- (2009) Yuki Kaneshiro et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy
- (2008) Susumu OGAWA et al. HYPERTENSION RESEARCH
- Azelnidipine Decreases Sympathetic Nerve Activity Via Antioxidant Effect in the Rostral Ventrolateral Medulla of Stroke-prone Spontaneously Hypertensive Rats
- (2008) Satomi Konno et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
- (2008) G.L. Bakris et al. KIDNEY INTERNATIONAL
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
- (2008) Kenneth Jamerson et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now